Overton, the US Food and Drug Administration nominee nominated by Trump, stated on mifepristone: According to the FDA review results, the drug meets safety and efficacy standards.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.